NTSIAVMC: Nationwide Treatment Survey of Intracranial Arteriovenous Malformation in China

Sponsor
Dr. Yong Cao (Other)
Overall Status
Unknown status
CT.gov ID
NCT01803685
Collaborator
(none)
1,000
1
30.9
32.3

Study Details

Study Description

Brief Summary

This register study will collect the treatment information of the intracranial arteriovenous malformation patients in China. We aim to understand the current treatment situation of the disease in China.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Intracranial arteriovenous malformations are congenital lesions that consist of multiple arteries and veins, connecting as a fistula without intervening normal capillary bed. The treatment strategy including surgical removal, endovascular embolism and stereotaxic radiosurgery and comprehensive treatment. China is a united multi-ethnic nation of 56 ethnic groups, and has the largest population in the world. We have most extensive and valuable clinical resources of intracranial arteriovenous malformation in the world. But we know little about the current treatment situation of the disease in China.

    In order to realize the treatment situation of intracranial arteriovenous malformation in China, we designed a retrospective and prospective register study to collect the treatment and outcome information all over China.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    1000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    A Nationwide Treatment Survey of Intracranial Arteriovenous Malformation: a Multicenter Retrospective and Prospective Register Study in China
    Study Start Date :
    Feb 1, 2013
    Anticipated Primary Completion Date :
    Jun 1, 2015
    Anticipated Study Completion Date :
    Sep 1, 2015

    Arms and Interventions

    Arm Intervention/Treatment
    Surgical treatment

    Surgical resection of intracranial arteriovenous malformations.

    Stereotaxic radiosurgery

    Deliver a relatively high dose of focused radiation precisely to the arteriovenous malformations.

    Endovascular treatment

    Deliver embolic materials to the feeding arteries or the nidus by microcatheters

    Comprehensive treatment

    Use two or three methods ( Surgical treatment stereotaxic radiosurgery endovascular treatment ) to cure the intracranial arteriovenous malformations

    Conservative treatment

    Patients refused to any of the treatment above

    Outcome Measures

    Primary Outcome Measures

    1. modified Ranking Scale [six months after operation]

      The scale runs from 0-6, running from perfect health without symptoms to death. 0 - No symptoms. - No significant disability. Able to carry out all usual activities, despite some symptoms. - Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. - Moderate disability. Requires some help, but able to walk unassisted. - Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. - Severe disability. Requires constant nursing care and attention, bedridden, incontinent. - Dead

    Secondary Outcome Measures

    1. Treatment complications [six months after treatment]

      Post operative epilepsy seizure, hemorrhage,infarction;cerebral edema态endovascular embolization injury

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • All the patients that diagnosed of intracranial AVM by DSA/CT/MRI

    • All patients gave written informed consent

    Exclusion Criteria:
    • patients refuse to attend the survey

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Neurosurgery, Beijing Tiantan Hospital Affiliated to Capital Medical University Beijing Beijing China 100050

    Sponsors and Collaborators

    • Dr. Yong Cao

    Investigators

    • Study Chair: Shuo Wang, MD, Beijing Tiantan Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Dr. Yong Cao, , Beijing Tiantan Hospital
    ClinicalTrials.gov Identifier:
    NCT01803685
    Other Study ID Numbers:
    • IAVM-125R
    First Posted:
    Mar 4, 2013
    Last Update Posted:
    Mar 4, 2013
    Last Verified:
    Mar 1, 2013

    Study Results

    No Results Posted as of Mar 4, 2013